October 18, 2012
The Office of the Inspector General (OIG) recently released its Work Plan for Fiscal Year 2013 (Work Plan) in which the OIG summarizes new and ongoing reviews and activities that it plans to pursue with respect to the Department of Health and Human Services programs and operations during 2013 and beyond.
The OIG has decided to focus its attention on five main areas of the Food and Drug Administration’s (FDA) oversight: